Cervical Cancer Test Market & Patients (Pap Smear, HPV DNA, VIA) in Asia (Japan, Korea, Singapore, Malaysia, India, China, Thailand, Indonesia)

January 2017 | 121 pages | ID: C99ABC2EBD7EN
Renub Research

Abstracts

Cervical cancer test market in Asian region is growing and expected to cross over Billion dollars by 2020. Despite declining women population, Japan has highest market share in cervical cancer test market. Whereas Indonesia is dominating in cervical cancer testing population followed by China. Growing women population, rising sum of structured cervical cancer programs introduced by governments and international NGOs and inception of low cost VIA test are some of the major growth drivers for the growth of cervical cancer test market in the developing countries.

Cervical Cancer Test Market & Patients (Pap Smear, HPV DNA, VIA) in Asia (Japan, Korea, Singapore, Malaysia, India, China, Thailand, Indonesia) report published by Renub Research provides a comprehensive analysis of this market and future evolution over the next 5 years. This 121 page report with 118 Figures and 4 Table provides a complete analysis of top 8 Countries Cervical Cancer Test Market & Population. All the 8 Asian countries in the report have been studied from 3 viewpoints.

Asia Cervical Cancer Test Market, Volume & Deaths

1. Cervical cancer Test Population (2008 – 2020)

• Pap smear test population (2008 – 2020)
• HPV DNA test population (2008 – 2020)
• VIA test Population (2008 – 2020)

2. Cervical Cancer Mortality Population (2001 – 2011)
3. Cervical Cancer Test Market (2008 – 2020)

• Pap smear test market (2008 – 2020)
• HPV DNA test market (2008 – 2020)
• VIA test market (2008 – 2020)

All the 8 Countries studied in the report are as follows

1. Japan
2. Korea
3. Singapore
4. Malaysia
5. India
6. China
7. Thailand
8. Indonesia

Data Sources

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts.

Primary sources include industry surveys and telephone interviews with industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 1000 paid databases.

Contents

1. EXECUTIVE SUMMARY

2. ASIA CERVICAL CANCER TEST (SCREENING) POPULATION & FORECAST

3. ASIA CERVICAL CANCER TEST (SCREENING) MARKET & FORECAST

3.1 Asia Cervical Cancer Pap Smear Test (Screening) Market & Forecast
3.2 Asia Cervical Cancer HPV DNA Test (Screening) Market & Forecast
3.3 Asia - Cervical Cancer Visual Inspection with Acetic Acid (VIA) Test (Screening) Market & Forecast

4. ASIA CERVICAL CANCER TEST (SCREENING) POPULATION SHARE & FORECAST

4.1 Asia Cervical Cancer Test (Screening) Population Share & Forecast

5. ASIA CERVICAL CANCER TEST (SCREENING) MARKET SHARE & FORECAST

5.1 Asia Cervical Cancer Test (Screening) Market Share & Forecast
5.2 Asia Cervical Cancer Pap Smear Test (Screening) Market Share & Forecast
5.3 Asia Cervical Cancer HPV DNA Test (Screening) Market Share & Forecast
5.4 Asia Cervical Cancer VIA Test (Screening) Market Share & Forecast

6. JAPAN – CERVICAL CANCER TEST ANALYSIS

6.1 Japan Cervical Cancer Test (Screening) Population
  6.1.1 Japan Cervical Cancer Pap Smear Test Population & Forecast
  6.1.2 Japan Cervical Cancer HPV DNA Test Population & Forecast
6.2 Japan Cervical Cancer Mortality
6.3 Japan Cervical Cancer Test (Screening) Market
  6.3.1 Japan Cervical Cancer Test Market & Forecast
  6.3.2 Japan Pap Smear Test Market & Forecast
  6.3.3 Japan HPV DNA Test Market & Forecast

7. SOUTH KOREA – CERVICAL CANCER TESTS ANALYSIS

7.1 South Korea - Cervical Cancer Test (Screening) Population
  7.1.1 South Korea - Cervical Cancer Pap Smear Test Population & Forecast
  7.1.2 Korea Cervical Cancer HPV DNA Test Population & Forecast
7.2 Korea Cervical Cancer Mortality
7.3 Korea Cervical Cancer Test (Screening) Market
  7.3.1 Korea Cervical Cancer Test Market & Forecast
  7.3.2 Korea Pap Smear Test Market & Forecast
  7.3.3 Korea HPV DNA Test Market & Forecast

8. SINGAPORE – CERVICAL CANCER TESTS ANALYSIS

8.1 Singapore - Cervical Cancer Test (Screening) Population
  8.1.1 Singapore - Cervical Cancer Pap Smear Test Population & Forecast
  8.1.2 Singapore Cervical Cancer HPV DNA Test Population & Forecast
8.2 Singapore Cervical Cancer Test (Screening) Market
  8.2.1 Singapore Cervical Cancer Test Market & Forecast
  8.2.2 Singapore Pap Smear Test Market & Forecast
  8.2.3 Singapore HPV DNA Test Market & Forecast

9. MALAYSIA – CERVICAL CANCER TEST ANALYSIS

9.1 Malaysia - Cervical Cancer Test (Screening) Population
  9.1.1 Malaysia Cervical Cancer Pap Smear Test Population & Forecast
  9.1.2 Malaysia Cervical Cancer HPV DNA Test Population & Forecast
9.2 Malaysia Cervical Cancer Test (Screening) Market
  9.2.1 Malaysia Cervical Cancer Test Market & Forecast
  9.2.2 Malaysia Pap Smear Test Market & Forecast
  9.2.3 Malaysia HPV DNA Test Market & Forecast

10. INDIA – CERVICAL CANCER TEST ANALYSIS

10.1 India - Cervical Cancer Test (Screening) Population
  10.1.1 India Cervical Cancer Pap Smear Test Population & Forecast
  10.1.2 India Cervical Cancer HPV DNA Test Population & Forecast
  10.1.3 India Cervical Cancer VIA Test Population & Forecast
10.2 India Cervical Cancer Test (Screening) Market
  10.2.1 India Cervical Cancer Test Market & Forecast
  10.2.2 India Pap Smear Test Market & Forecast
  10.2.3 India HPV DNA Test Market & Forecast
  10.2.4 India VIA Test Market & Forecast

11. CHINA – CERVICAL CANCER TEST ANALYSIS

11.1 China - Cervical Cancer Test (Screening) Population
  11.1.1 China Cervical Cancer Pap smear Test Population & Forecast
  11.1.2 China Cervical Cancer HPV DNA Test Population & Forecast
  11.1.3 China Cervical Cancer VIA Test Population & Forecast
11.2 China - Cervical Cancer Test (Screening) Market
  11.2.1 China Cervical Cancer Test Market & Forecast
  11.2.2 China Pap Smear Test Market & Forecast
  11.2.3 China HPV DNA Test Market & Forecast
  11.2.4 China VIA Test Market & Forecast

12. THAILAND – CERVICAL CANCER TEST ANALYSIS

12.1 Thailand - Cervical Cancer Test (Screening) Population
  12.1.1 Thailand Cervical Cancer Pap Smear Test Population & Forecast
  12.1.2 Thailand Cervical Cancer VIA Test Population & Forecast
12.2 Thailand Cervical Cancer Test (Screening) Market
  12.2.1 Thailand Cervical Cancer Test Market & Forecast
  12.2.2 Thailand Pap smear Test Market & Forecast
  12.2.3 Thailand VIA Test Market & Forecast

13. INDONESIA – CERVICAL CANCER TEST ANALYSIS

13.1 Indonesia Cervical Cancer Test (Screening) Population
  13.1.1 Indonesia Cervical Cancer Pap Smear Test Population & Forecast
  13.1.2 Indonesia Cervical Cancer HPV DNA Test Population & Forecast
  13.1.3 Indonesia Cervical Cancer VIA Test Population & Forecast
  13.1.4 Indonesia Cervical Cancer Both (Pap Smear & VIA) Test Population & Forecast
13.2 Indonesia Cervical Cancer Test (Screening) Market
  13.2.1 Indonesia Cervical Cancer Test Market & Forecast
  13.2.2 Indonesia Pap smear Test Market & Forecast
  13.2.3 Indonesia HPV DNA Test Market & Forecast
  13.2.4 Indonesia VIA Test Market & Forecast
  13.2.5 Indonesia Cervical Cancer Both (Pap Smear & VIA) Test Market & Forecast

14. CERVICAL CANCER TEST MARKET GROWTH DRIVERS

14.1 Introduction of Low Cost VIA Test
  14.1.1 Countries Offering VIA Test via National Programs
  14.1.2 Countries Offering VIA Test via Pilot Programs
14.2 Worldwide Rising Incidence of Teenage Sexual Cases
14.3 High Prevalence of HPV Infected Patients Globally

15. CHALLENGES IN CERVICAL CANCER TEST MARKET

15.1 Lack of Appropriate Healthcare Infrastructure
15.2 Introduction of HPV Vaccination Programs Worldwide

List Of Figures

LIST OF FIGURES:

Figure 2 1: Asia – Cervical Cancer Test Population (Million), 2008 – 2015
Figure 2 2: Asia – Forecast for Cervical Cancer Test Population (Million), 2016 – 2020
Figure 3 1: Asia – Cervical Cancer Test Market (Million US$), 2008 – 2015
Figure 3 2: Asia – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020
Figure 3 3: Asia – Cervical Cancer Pap Smear Test Market (Million US$), 2008 – 2015
Figure 3 4: Asia – Forecast for Cervical Cancer Pap Smear Test Market (Million US$), 2016 – 2020
Figure 3 5: Asia – Cervical Cancer HPV DNA Test Market (Million US$), 2008 – 2015
Figure 3 6: Asia – Forecast for Cervical Cancer HPV DNA Test Market (Million US$), 2016 – 2020
Figure 3 7: Asia – Cervical Cancer VIA Test Market (Million US$), 2008 – 2015
Figure 3 8: Asia – Forecast for Cervical Cancer VIA Test Market (Million US$), 2016 – 2020
Figure 4 1: Asia – Cervical Cancer Test Population Share (Percent), 2008 – 2015
Figure 4 2: Asia – Forecast for Cervical Cancer Test Population Share (Percent), 2016 – 2020
Figure 5 1: Asia – Cervical Cancer Test Market Share (Percent), 2008 – 2015
Figure 5 2: Asia – Forecast for Cervical Cancer Test Market Share (Percent), 2016 – 2020
Figure 5 3: Asia – Cervical Cancer Pap Smear Test Market Share (Percent), 2008 – 2015
Figure 5 4: Asia – Forecast for Cervical Cancer Pap Smear Test Market Share (Percent), 2016 – 2020
Figure 5 5: Asia – Cervical Cancer HPV DNA Test Market Share (Percent), 2008 – 2015
Figure 5 6: Asia – Forecast for Cervical Cancer HPV DNA Test Market Share (Percent), 2016 – 2020
Figure 5 7: Asia – Cervical Cancer VIA Test Market Share (Percent), 2008 – 2015
Figure 5 8: Asia – Forecast for Cervical Cancer VIA Test Market Share (Percent), 2016 – 2020
Figure 6 1: Japan – Cervical Cancer Pap Smear Test Population (Thousand), 2008 – 2015
Figure 6 2: Japan – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 – 2020
Figure 6 3: Japan – Cervical Cancer HPV DNA Test Population (Thousand), 2008 – 2015
Figure 6 4: Japan – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 – 2020
Figure 6 5: Japan – Cervical Cancer Mortality (Number), 2001 – 2011
Figure 6 6: Japan – Cervical Cancer Test Market (Million US$), 2008 – 2015
Figure 6 7: Japan – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020
Figure 6 8: Japan – Pap Smear Test Market (Million US$), 2008 – 2015
Figure 6 9: Japan – Forecast for Pap Smear Test Market (Million US$), 2016 – 2020
Figure 6 10: Japan – HPV DNA Test Market (Million US$), 2008 – 2015
Figure 6 11: Japan – Forecast for HPV DNA Test Market (Million US$), 2016 – 2020
Figure 7 1: Korea – Cervical Cancer Pap Smear Test Population (Thousand), 2008 – 2015
Figure 7 2: Korea – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 – 2020
Figure 7 3: Korea – Cervical Cancer HPV DNA Test Population (Thousand), 2008 – 2015
Figure 7 4: Korea – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 – 2020
Figure 7 5: Korea – Cervical Cancer Mortality (Number), 2001 – 2011
Figure 7 6: Korea – Cervical Cancer Test Market (Million US$), 2008 – 2015
Figure 7 7: Korea – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020
Figure 7 8: Korea – Pap Smear Test Market (Million US$), 2008 – 2015
Figure 7 9: Korea – Forecast for Pap Smear Test Market (Million US$), 2016 – 2020
Figure 7 10: Korea – HPV DNA Test Market (Million US$), 2008 – 2015
Figure 7 11: Korea – Forecast for HPV DNA Test Market (Million US$), 2016 – 2020
Figure 8 1: Singapore – Cervical Cancer Pap Smear Test Population (Thousand), 2008 – 2015
Figure 8 2: Singapore – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 – 2020
Figure 8 3: Singapore – Cervical Cancer HPV DNA Test Population (Thousand), 2008 – 2015
Figure 8 4: Singapore – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 – 2020
Figure 8 5: Singapore – Cervical Cancer Test Market (Million US$), 2008 – 2015
Figure 8 6: Singapore – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020
Figure 8 7: Singapore – Pap Smear Test Market (Million US$), 2008 – 2015
Figure 8 8: Singapore – Forecast for Pap Smear Test Market (Million US$), 2016 – 2020
Figure 8 9: Singapore – HPV DNA Test Market (Million US$), 2008 – 2015
Figure 8 10: Singapore – Forecast for HPV DNA Test Market (Million US$), 2016 – 2020
Figure 9 1: Malaysia – Cervical Cancer Pap Smear Test Population (Thousand), 2008 – 2015
Figure 9 2: Malaysia – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 – 2020
Figure 9 3: Malaysia – Cervical Cancer HPV DNA Test Population (Thousand), 2008 – 2015
Figure 9 4: Malaysia – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 – 2020
Figure 9 5: Malaysia – Cervical Cancer Test Market (Million US$), 2008 – 2015
Figure 9 6: Malaysia – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020
Figure 9 7: Malaysia – Pap smear Test Market (Million US$), 2008 – 2015
Figure 9 8: Malaysia – Forecast for Pap smear Test Market (Million US$), 2016 – 2020
Figure 9 9: Malaysia – HPV DNA Test Market (Million US$), 2008 – 2015
Figure 9 10: Malaysia – Forecast for HPV DNA Test Market (Million US$), 2016 – 2020
Figure 10 1: India – Cervical Cancer Pap Smear Test Population (Thousand), 2008 – 2015
Figure 10 2: India – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 – 2020
Figure 10 3: India – Cervical Cancer HPV DNA Test Population (Thousand), 2008 – 2015
Figure 10 4: India – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 – 2020
Figure 10 5: India – Cervical Cancer VIA Test Population (Thousand), 2008 – 2015
Figure 10 6: India – Forecast for Cervical Cancer VIA Test Population (Thousand), 2016 – 2020
Figure 10 7: India – Cervical Cancer Test Market (Million US$), 2008 – 2015
Figure 10 8: India – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020
Figure 10 9: India – Pap smear Test Market (Million US$), 2008 – 2015
Figure 10 10: India – Forecast for Pap smear Test Market (Million US$), 2016 – 2020
Figure 10 11: India – HPV DNA Test Market (Million US$), 2008 – 2015
Figure 10 12: India – Forecast for HPV DNA Test Market (Million US$), 2016 – 2020
Figure 10 13: India – VIA Test Market (Million US$), 2008 – 2015
Figure 10 14: India – Forecast for VIA Test Market (Million US$), 2016 – 2020
Figure 11 1: China – Cervical Cancer Pap Smear Test Population (Thousand), 2008 – 2015
Figure 11 2: China – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 – 2020
Figure 11 3: China – Cervical Cancer HPV DNA Test Population (Thousand), 2008 – 2015
Figure 11 4: China – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 – 2020
Figure 11 5: China – Cervical Cancer VIA Test Population (Thousand), 2008 – 2015
Figure 11 6: China – Forecast for Cervical Cancer VIA Test Population (Thousand), 2016 – 2020
Figure 11 7: China – Cervical Cancer Test Market (Million US$), 2008 – 2015
Figure 11 8: China – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020
Figure 11 9: China – Pap smear Test Market (Million US$), 2008 – 2015
Figure 11 10: China – Forecast for Pap Smear Test Market (Million US$), 2016 – 2020
Figure 11 11: China – HPV DNA Test Market (Million US$), 2008 – 2015
Figure 11 12: China – Forecast for HPV DNA Test Market (Million US$), 2016 – 2020
Figure 11 13: China – VIA Test Market (Million US$), 2008 – 2015
Figure 11 14: China – Forecast for VIA Test Market (Million US$), 2016 – 2020
Figure 12 1: Thailand – Cervical Cancer Pap Smear Test Population (Thousand), 2008 – 2015
Figure 12 2: Thailand – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 – 2020
Figure 12 3: Thailand – Cervical Cancer VIA Test Population (Thousand), 2008 – 2015
Figure 12 4: Thailand – Forecast for Cervical Cancer VIA Test Population (Thousand), 2016 – 2020
Figure 12 5: Thailand – Cervical Cancer Test Market (Million US$), 2008 – 2015
Figure 12 6: Thailand – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020
Figure 12 7: Thailand – Pap smear Test Market (Million US$), 2008 – 2015
Figure 12 8: Thailand – Forecast for Pap Smear Test Market (Million US$), 2016 – 2020
Figure 12 9: Thailand – VIA Test Market (Million US$), 2008 – 2015
Figure 12 10: Thailand – Forecast for VIA Test Market (Million US$), 2016 – 2020
Figure 13 1: Indonesia – Cervical Cancer Pap Smear Test Population (Thousand), 2008 – 2015
Figure 13 2: Indonesia – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 – 2020
Figure 13 3: Indonesia – Cervical Cancer HPV DNA Test Population (Thousand), 2008 – 2015
Figure 13 4: Indonesia – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 – 2020
Figure 13 5: Indonesia – Cervical Cancer VIA Test Population (Thousand), 2008 – 2015
Figure 13 6: Indonesia – Forecast for Cervical Cancer VIA Test Population (Thousand), 2016 – 2020
Figure 13 7: Indonesia – Cervical Cancer Both (Pap Smear & VIA) Test Population (Thousand), 2008 – 2015
Figure 13 8: Indonesia – Forecast for Cervical Cancer Both (Pap Smear & VIA) Test Population (Thousand), 2016 – 2020
Figure 13 9: Indonesia – Cervical Cancer Test Market (Million US$), 2008 – 2015
Figure 13 10: Indonesia – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020
Figure 13 11: Indonesia – Pap Smear Test Market (Million US$), 2008 – 2015
Figure 13 12: Indonesia – Forecast for Pap Smear Test Market (Million US$), 2016 – 2020
Figure 13 13: Indonesia – HPV DNA Test Market (Million US$), 2008 – 2015
Figure 13 14: Indonesia – Forecast for HPV DNA Test Market (Million US$), 2016 – 2020
Figure 13 15: Indonesia – VIA Test Market (Million US$), 2008 – 2015
Figure 13 16: Indonesia – Forecast for VIA Test Market (Million US$), 2016 – 2020
Figure 13 17: Indonesia – Both (Pap smear & VIA) Test Market (Million US$), 2008 – 2015
Figure 13 18: Indonesia – Forecast for Both (Pap Smear & VIA) Test Market (Million US$), 2016 – 2020

List Of Tables

LIST OF TABLES:

Table 25 1: Worldwide – List of Countries which offer VIA Test via National Programs, 2015
Table 25 2: Worldwide – List of Countries which offer VIA Test via Pilot Programs, 2015
Table 25 3: Worldwide – Prevalence (Percent) of Young Women (15–44 Years) who Have Sex before the Age of 15 Years, 1994 – 2006
Table 25 4: Worldwide – HPV Prevalence (Percent) among Women with Normal Cervical Cytology, 2010